Pure Global: US/EU AI Imaging & The Dual-Approval Gambit

About this episode

This episode discusses Abbott's dual-market approval for its AI-powered imaging software and the strategies behind navigating complex regulatory systems in the U.S. and Europe.

This week on MedTech Global Insights, we dissect a major strategic win in the cardiovascular space. Abbott's recent dual-market approval for its AI-powered imaging software in both the U.S. and Europe is more than just a headline—it's a blueprint for successful global regulatory strategy. We explore how they navigated two of the world's most difficult regulatory systems at the same time. This episode delves into the specific challenges of aligning the FDA's 510(k) process with Europe's stringent MDR requirements. For any company struggling to create a regulatory submission for one market, the idea of tackling both simultaneously seems impossible. We break down the likely strategies that made it happen and what lessons startups and multinational companies alike can learn from this landmark achievement. Key Takeaways: -Why is achieving simultaneous FDA clearance and CE marking so rare for complex software devices? -What are the critical differences between a U.S. 510(k) file and an EU MDR technical dossier? -How can a company build a single set of clinical data to satisfy both American and European regulators? -What does Abbott's success signal for the future of AI-driven medical…

People in this episode

Host: Ran Chen

Topics covered

• regulatory strategy
• AI in healthcare
• global market approval
• FDA clearance
• CE marking
• clinical data
• quality management

Keywords

• dual-market approval
• AI imaging
• regulatory challenges
• FDA 510(k)
• EU MDR
• clinical data harmonization
• global-first strategy

Mentioned in this episode

Organizations: Abbott, FDA, EU, MDR

Products: AI-powered imaging software

More episodes of MedTech Global Insights

• Pure Global: US AI MedTech Rules & The Global Fallout. · May 7, 2026 · 2 min
• Pure Global: USA's LDT Overhaul - Navigating the FDA's New IVD Era · May 6, 2026 · 2 min
• USA MedTech M&A: Pure Global on The Deal Frenzy of 2026. · May 5, 2026 · 2 min
• Pure Global: US Cyber Rules & The MedTech Rejection Wave · May 4, 2026 · 2 min
• EU's AI-MDR Maze: Pure Global on Dual Regulation Traps · May 3, 2026 · 2 min
• USA 510(k) Cybersecurity: Pure Global on the New Hidden Hurdles · May 1, 2026 · 2 min